Variants in exon 2 of MED12 gene causes uterine leiomyoma's through over-expression of MMP-9 of ECM pathway

• Published in: Mutation research Vol. 828; p. 111839
• Main Authors: Pandey, Vivek, Jain, Priyanka, Chatterjee, Souradip, Rani, Anjali, Tripathi, Anima, Dubey, Pawan K
• Format: Journal Article
• Language: English
• Published: Netherlands 01-01-2024
• Subjects: Adult; Exons; Extracellular Matrix - genetics; Extracellular Matrix - metabolism; Female; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma - genetics; Leiomyoma - metabolism; Leiomyoma - pathology; Matrix Metalloproteinase 9 - genetics; Matrix Metalloproteinase 9 - metabolism; Mediator Complex - genetics; Mediator Complex - metabolism; Middle Aged; Mutation, Missense; Uterine Neoplasms - genetics; Uterine Neoplasms - metabolism; Uterine Neoplasms - pathology; MED-12; Uterine leiomyoma’s; Exon2; Somatic Mutation
• ISSN: 1873-135X
• DOI: 10.1016/j.mrfmmm.2023.111839

To study the impact of Mediator complex subunit 12 (MED12) gene variants on the encoded protein's function and pathogenic relevance for genesis of uterine leiomyoma's (ULs).
Mutational analysis in exon-2 of MED12 gene was performed by PCR amplification and DNA sequencing in 89 clinically diagnosed ULs tissues. Pathogenicity prediction of variation was performed by computational analysis. The functional effects of missense variation were done by quantity RT-PCR and western blot analysis.
Out of 89 samples, 40 (44.94%) had missense variation in 14 different CDS position of exon-2 of MED12 gene. Out of 40 missense variation, codon 44 had 25 (62.5%) looking as a hotspot region for mutation for ULs, because CDS position c130 and c131present at codon 44 that have necleotide change G>A, T, C at c130 and c131 have necleotide change G>A and C. We also find somenovel somatic mutations oncodon 36 (T > C), 38 (G>T) of exon-2 and 88 (G>C) of intron-2. No mutations were detected in uterine myometrium samples. Our computational analysis suggests that change in Med12c .131 G>A leads to single substitution of amino acid [Glycine (G) to Aspartate (D)] which has a pathogenic and lethal impact and may cause instability of MED12 protein. Further, analysis of extracellular matrix (ECM) component (MMP-2 & 9, COL4A2 and α-SMA) mRNA and protein expression levels in the set of ULs having MED12 mutation showed significantly higher expression of MMP-9 and α-SMA.
The findings of present study suggest that missense variation in codon 44 of MED12 gene lead to the genesis of leiomyoma's through over-expression of MMP-9 of ECM pathway which could be therapeutically targeted for non-surgical management of ULs.